
Beta Bionics Faces Class Action Over Alleged iLet Safety Failures
Investors in Beta Bionics have initiated a class action lawsuit in the U.S. District Court for the Central District of California, alleging the company misled the market regarding the safety and performance of its iLet insulin delivery system, triggering a sharp decline in shareholder value earlier this year.

























